Education
About Us
Working with TipRanks
Follow Us
Tempest Therapeutics (TPST)
NASDAQ:TPST
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -389.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ -815.00K |
| Operating Income | $ -42.03M | $ -29.16M | $ -34.64M | $ -26.99M | $ -19.30M |
| EBITDA | $ -40.14M | $ -27.66M | $ -33.45M | $ -26.65M | $ -18.39M |
| Net Income | $ -41.84M | $ -29.49M | $ -35.71M | $ -28.30M | $ -19.12M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 30.27M | $ 39.23M | $ 31.23M | $ 51.83M | $ 18.82M |
| Total Assets | $ 41.49M | $ 51.60M | $ 46.09M | $ 73.24M | $ 22.86M |
| Total Debt | $ 15.37M | $ 20.66M | $ 22.11M | $ 18.54M | $ 2.44M |
| Net Debt | $ -14.90M | $ -18.57M | $ -9.12M | $ -33.29M | $ -16.38M |
| Total Liabilities | $ 22.36M | $ 24.84M | $ 27.98M | $ 37.12M | $ 91.66M |
| Stockholders' Equity | $ 19.13M | $ 26.77M | $ 18.11M | $ 36.12M | $ -68.79M |
| Cash Flow | |||||
| Free Cash Flow | $ -33.46M | $ -27.53M | $ -31.63M | $ -26.09M | $ -19.07M |
| Operating Cash Flow | $ -33.03M | $ -27.36M | $ -31.07M | $ -25.96M | $ -19.02M |
| Investing Cash Flow | $ -435.00K | $ -170.00K | $ -562.00K | $ -97.00K | $ -6.00K |
| Financing Cash Flow | $ 24.50M | $ 35.60M | $ 11.40M | $ 59.06M | $ 34.60M |